Busey Bank’s Novo Nordisk NVO Stock Holding History

Busey Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Sell	7,825 -635	-8%	-$27.3K	0.01%	283
2026 Q1	$311K	Sell	8,460 -2,835	-25%	-$134K	0.01%	299
2025 Q4	$575K	Sell	11,295 -3,758	-25%	-$192K	0.02%	232
2025 Q3	$835K	Sell	15,053 -106,586	-88%	-$6.24M	0.02%	194
2025 Q2	$8.4M	Buy	121,639 +5,106	+4%	+$347K	0.26%	86
2025 Q1	$8.09M	Buy	116,533 +10,099	+9%	+$834K	0.27%	87
2024 Q4	$9.16M	Buy	106,434 +55,380	+108%	+$5.99M	0.3%	80
2024 Q3	$6.08M	Buy	51,054 +1,895	+4%	+$253K	0.2%	100
2024 Q2	$7.02M	Buy	49,159 +1,970	+4%	+$261K	0.24%	93
2024 Q1	$6.06M	Buy	47,189 +42,720	+956%	+$5.09M	0.22%	98
2023 Q4	$462K	Buy	+4,469	New	+$442K	0.02%	243
2020 Q1	–	Sell	-400	Closed	-$12K	–	403
2019 Q4	$12K	Buy	+400	New	+$11.1K	﹤0.01%	424

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Busey Bank's NVO Position: Q2 2026 in Review

Busey Bank reduced its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, selling an estimated $27.3K and leaving 7,825 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #283.

Busey Bank first reported a position in NVO in Q4 2019 and has held it in 12 quarters since. The position peaked at $9.16M in Q4 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Busey Bank held 7,825 shares of Novo Nordisk worth $375K as of Q2 2026.
Busey Bank sold 635 Novo Nordisk shares in Q2 2026, an estimated $27.3K.
Novo Nordisk made up 0.01% of Busey Bank's portfolio in Q2 2026, its #283 holding.
Busey Bank first reported a position in Novo Nordisk in Q4 2019 and has held it in 12 quarters since.
Busey Bank's Novo Nordisk position peaked at $9.16M in Q4 2024.
1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Busey Bank's 13F filing for Q2 2026, filed 13 Aug 2026.